A large study revealed that severe valvular heart disease is common among cancer patients and is associated with poorer ...

Multivalvular disease (MVD) is a prevalent form of valvular heart disease; rheumatic heart disease is the predominant aetiology in developing countries, whereas degenerative aetiologies are ...

Transcatheter aortic valve replacement (TAVR) appears to be a safe and effective treatment for patients with severe aortic valve regurgitation alone who are not candidates for surgery, according to a ...

Heart with coronary vessels inside human body, computer illustration. Patients who have truncus arteriosus with moderate or worse initial truncal valve regurgitation or stenosis may be at risk for ...

PARIS -- The early commercial experience with transcatheter aortic valve replacement (TAVR or TAVI) for severe aortic regurgitation appeared promising, though device size issues and conduction ...

Please provide your email address to receive an email when new articles are posted on . Rahimi and colleagues investigated the relationship between high BP, aortic stenosis and aortic regurgitation in ...

On clinical grounds she was thought to have significant mitral regurgitation as well as stenosis. Retrograde catheterization showed a pulmonary-capillary-left-ventricle diastolic gradient of 13 mm. of ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Aortic valve disease is a condition that occurs when your aorta (the main artery of your body) and left ventricle (the lower left chamber of your heart) malfunction. The aortic valve determines how ...

Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...